A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation
{{output}}
Objective: To evaluate the feasibility, efficacy, and safety of high dose immunosuppressive therapy (HDIT) and autologous hemopoietic stem cell transplantation (HSCT) with CD34+ cell selection in patients with severe, refractory ... ...
